SEC 13F Intelligence

Saturna Capital Corp / ELV

Saturna Capital Corp’s Elevance Health Inc Formerly Position

Does Saturna Capital Corp own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 209.9K shares worth $109M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$109M
Q3 2024
Shares
209.9K
% of Portfolio
+1.43%
Quarters Held
9
position exited

Position History ELV

Reported value by quarter
Q3 ’22: $63MQ3 ’22Q4 ’22: $71MQ1 ’23: $64MQ1 ’23Q2 ’23: $75MQ3 ’23: $81MQ3 ’23Q4 ’23: $87MQ1 ’24: $109MQ1 ’24Q2 ’24: $114MQ3 ’24: $109MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024209.9K$109M+1.43%
Q2 2024209.9K$114M+1.51%
Q1 2024209.9K$109M+1.50%
Q4 2023184.9K$87M+1.36%
Q3 2023185.2K$81M+1.43%
Q2 2023168.2K$75M+1.29%
Q1 2023139.1K$64M+1.24%
Q4 2022139.1K$71M+1.54%
Q3 2022139.1K$63M+1.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saturna Capital Corp’s full portfolio or all institutional holders of ELV.